Inorganic selenium retards progression of experimental hormone refractory prostate cancer.
about
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancerSubchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.Selenium inhibition of survivin expression by preventing Sp1 binding to its promoterMethyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefitIn vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.Selenium supplementation and prostate cancer mortalitySoy content of basal diets determines the effects of supplemental selenium in male miceStatus of selenium in prostate cancer preventionSuperior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.Complementary and alternative medicines in prostate cancer: from bench to bedside?The effects of selenium on tumor growth in epithelial ovarian carcinomaMultifocal angiostatic therapy: an update.Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cellsCancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.The regulatory roles of phosphatases in cancer.Comparative proteomics analysis of sodium selenite-induced apoptosis in human prostate cancer cells.Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.Combined low-dose imatinib mesylate and paclitaxel lack synergy in an experimental model of extra-osseous hormone-refractory prostate cancer.
P2860
Q24657886-9C9400E3-B9F7-4EA8-9429-EC480342EFF1Q33377810-A6F18DB4-A0E1-409F-B645-DD1A17D0C136Q33573583-631170D1-F966-4549-9037-DA606F39D104Q33652526-A62BB11D-B2FE-4B7C-8DE0-74DED3B2F19FQ33657004-C7CA5832-9266-4CD9-B00C-30938262EE9CQ33657012-B6D03EC1-8175-4B49-9F08-940C0BEA77C6Q34074062-621C8056-2C61-486E-9227-AD42B07B078FQ34440647-DE01B866-503E-4271-A267-D752D5372317Q34500651-B75577AA-F852-40DB-A748-AEF7DC81EF22Q34974869-D77CF733-E09D-49FF-B5EA-533A0E6ACD67Q35572551-616924E4-F304-448B-B113-0538903D6D12Q35815001-B85C8764-D787-48A6-BB21-3BD18281D42AQ35853576-10E50307-12F3-41B3-BF67-05AAD9E84422Q36051522-5F343791-9112-4B20-98B8-E481E01AC7F8Q36090099-AC41D549-7159-4BC9-9420-2056EAE64ACBQ36311166-1B4D9427-41A7-4268-8549-D053C8EDC430Q36429602-CD464967-89A1-4263-993A-4142C590777CQ36769227-7D5F8B57-1943-4A49-A2BB-6B8256AD0D07Q38090432-63CD5EDC-DC42-4769-9213-30141D545FE4Q39165894-BDCECB2D-3A80-442F-83F8-F79CD696A269Q40161758-8AABCEBF-E214-43E5-8180-7A0DE9DD344BQ41877172-47EB458E-BC5E-4CD8-8CD2-E38D015B558DQ46654052-A48F2D91-7C4D-4CA0-98F8-F3E3639F24A2
P2860
Inorganic selenium retards progression of experimental hormone refractory prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inorganic selenium retards pro ...... ne refractory prostate cancer.
@en
type
label
Inorganic selenium retards pro ...... ne refractory prostate cancer.
@en
prefLabel
Inorganic selenium retards pro ...... ne refractory prostate cancer.
@en
P2093
P1476
Inorganic selenium retards pro ...... ne refractory prostate cancer.
@en
P2093
Anthony J Costello
Meri Najdovska
Niall M Corcoran
P304
P356
10.1097/01.JU.0000092859.16817.8E
P407
P433
P577
2004-02-01T00:00:00Z